GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Biotage AB (OSTO:BIOT) » Definitions » Cyclically Adjusted FCF per Share

Biotage AB (OSTO:BIOT) Cyclically Adjusted FCF per Share : kr3.00 (As of Mar. 2024)


View and export this data going back to 2000. Start your Free Trial

What is Biotage AB Cyclically Adjusted FCF per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

Biotage AB's adjusted free cash flow per share for the three months ended in Mar. 2024 was kr0.837. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is kr3.00 for the trailing ten years ended in Mar. 2024.

During the past 12 months, Biotage AB's average Cyclically Adjusted FCF Growth Rate was 17.60% per year. During the past 3 years, the average Cyclically Adjusted FCF Growth Rate was 23.90% per year. During the past 5 years, the average Cyclically Adjusted FCF Growth Rate was 26.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted FCF Growth Rate of Biotage AB was 28.00% per year. The lowest was 22.10% per year. And the median was 25.70% per year.

As of today (2024-05-17), Biotage AB's current stock price is kr179.50. Biotage AB's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2024 was kr3.00. Biotage AB's Cyclically Adjusted Price-to-FCF of today is 59.83.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Biotage AB was 155.80. The lowest was 31.41. And the median was 100.12.


Biotage AB Cyclically Adjusted FCF per Share Historical Data

The historical data trend for Biotage AB's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biotage AB Cyclically Adjusted FCF per Share Chart

Biotage AB Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.22 1.53 1.95 2.56 2.91

Biotage AB Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.55 2.65 2.77 2.91 3.00

Competitive Comparison of Biotage AB's Cyclically Adjusted FCF per Share

For the Medical Instruments & Supplies subindustry, Biotage AB's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Biotage AB's Cyclically Adjusted Price-to-FCF Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Biotage AB's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Biotage AB's Cyclically Adjusted Price-to-FCF falls into.



Biotage AB Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Biotage AB's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2024 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=0.837/132.2054*132.2054
=0.837

Current CPI (Mar. 2024) = 132.2054.

Biotage AB Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201406 0.260 100.432 0.342
201409 0.151 100.161 0.199
201412 0.328 100.225 0.433
201503 0.285 99.950 0.377
201506 0.335 99.995 0.443
201509 0.385 100.228 0.508
201512 0.356 100.276 0.469
201603 0.443 100.751 0.581
201606 0.263 101.019 0.344
201609 0.326 101.138 0.426
201612 0.383 102.022 0.496
201703 0.357 102.022 0.463
201706 0.500 102.752 0.643
201709 0.338 103.279 0.433
201712 0.830 103.793 1.057
201803 0.233 103.962 0.296
201806 0.203 104.875 0.256
201809 0.584 105.679 0.731
201812 0.646 105.912 0.806
201903 0.024 105.886 0.030
201906 0.481 106.742 0.596
201909 1.077 107.214 1.328
201912 0.969 107.766 1.189
202003 0.705 106.563 0.875
202006 0.641 107.498 0.788
202009 0.966 107.635 1.187
202012 1.043 108.296 1.273
202103 0.767 108.360 0.936
202106 1.164 108.928 1.413
202109 1.209 110.338 1.449
202112 1.394 112.486 1.638
202203 0.650 114.825 0.748
202206 1.058 118.384 1.182
202209 1.209 122.296 1.307
202212 1.178 126.365 1.232
202303 -0.121 127.042 -0.126
202306 0.474 129.407 0.484
202309 0.999 130.224 1.014
202312 1.536 131.912 1.539
202403 0.837 132.205 0.837

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.


Biotage AB  (OSTO:BIOT) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

Biotage AB's Cyclically Adjusted Price-to-FCF of today is calculated as

Cyclically Adjusted Price-to-FCF=Share Price/Cyclically Adjusted FCF per Share
=179.50/3
=59.83

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Biotage AB was 155.80. The lowest was 31.41. And the median was 100.12.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


Biotage AB Cyclically Adjusted FCF per Share Related Terms

Thank you for viewing the detailed overview of Biotage AB's Cyclically Adjusted FCF per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Biotage AB (OSTO:BIOT) Business Description

Traded in Other Exchanges
Address
Vimpelgatan 5, Box 8, Uppsala, SWE, 751 03
Biotage AB provides separation technology and solutions for analytical and organic chemistry from research to commercial analytical laboratories and industrial applications. Its customers span a broad range of market segments including pharmaceutical, biotech, diagnostic, contract research, and contract manufacturers as well as clinical, forensic, and academic laboratories in addition to organizations focused on food safety, clean water, and environmental sustainability. It serves three geographic markets: The Americas, APAC (Asia-Pacific,) and EMEA (Europe, Middle East & Africa). The company's product areas include Small Molecules & Synthetic Therapeutics, Biologics & Advanced Therapeutics, Scale-Up, Diagnostics, Analytical Testing, and Water & Environmental Testing.

Biotage AB (OSTO:BIOT) Headlines

From GuruFocus